|
|
||||||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The content, binding affinity and bioactivity of chicken II GnRH (GnRH II) and a stable analog of GnRH II (GnRH II analog) in the baboon ovary were studied. While mammalian GnRH is rapidly degraded by baboon ovarian extracts, we have designed a GnRH II analog, which is stable to ovarian enzymatic degradation. This analog of GnRH II was found to bind to the ovarian membranes with high affinity (41 ± 3 nM), having 20-fold the affinity of Buserelin, a mammalian GnRH analog. The bioactivity of GnRH II and this GnRH II analog on the regulation of ovarian progesterone release was compared to that for Buserelin using a baboon granulosa cell culture system. Both GnRH II and GnRH II analog effected a significant inhibition of progesterone release from the granulosa cells (p<0.03 and p< 0.005, respectively) with a greater reduction observed using the GnRH II analog. After 24 hours in culture this GnRH II analog effected a 59 ± 5% inhibition of progesterone using a concentration as low as1 nM. A maximal inhibition of 75 ± 1% was attained with 10 nM GnRH II analog. The endogenous GnRH II content in the baboon ovary was 5-14 pmoles/g protein. The release of endogenous GnRH II from granulosa cells was observed throughout the forty-eight hours in culture. These studies demonstrate the presence of high enzymatic activity for the degradation of mammalian GnRH in the ovary, while this GnRH II analog was stable. The presence of high affinity binding sites for this GnRH II analog was found. In addition, we have shown that GnRH II and this GnRH II analog can regulate progesterone production from baboon granulosa cells. These findings have led us to propose that GnRH II is a potent regulator of ovarian function.
This article has been cited by other articles:
![]() |
K.-Y. Kim, K.-C. Choi, S.-H. Park, N. Auersperg, and P. C. K. Leung Extracellular Signal-Regulated Protein Kinase, But Not c-Jun N-Terminal Kinase, Is Activated by Type II Gonadotropin-Releasing Hormone Involved in the Inhibition of Ovarian Cancer Cell Proliferation J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1670 - 1677. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Ding, J. Xu, X. Luo, and N. Chegini Gonadotropin Releasing Hormone and Transforming Growth Factor {beta} Activate Mitogen-Activated Protein Kinase/Extracellularly Regulated Kinase and Differentially Regulate Fibronectin, Type I Collagen, and Plasminogen Activator Inhibitor-1 Expression in Leiomyoma and Myometrial Smooth Muscle Cells J. Clin. Endocrinol. Metab., November 1, 2004; 89(11): 5549 - 5557. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. M. Siler-Khodr, F.-Q. Yu, P. Wei, S.-X. Tao, and Y.-X. Liu Contraceptive Action of a Gonadotropin-Releasing Hormone II Analog in the Rhesus Monkey J. Clin. Endocrinol. Metab., September 1, 2004; 89(9): 4513 - 4520. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. A. Mongiat, V. A. Lux-Lantos, and C. Libertun Evidence for Different Gonadotropin-Releasing Hormone Response Sites in Rat Ovarian and Pituitary Cells Biol Reprod, August 1, 2004; 71(2): 464 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-Y. Kim, K.-C. Choi, S.-H. Park, C.-S. Chou, N. Auersperg, and P. C. K. Leung Type II Gonadotropin-Releasing Hormone Stimulates p38 Mitogen-Activated Protein Kinase and Apoptosis in Ovarian Cancer Cells J. Clin. Endocrinol. Metab., June 1, 2004; 89(6): 3020 - 3026. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |